What similar problems are encountered with antiviral, antifungal, antiprotozoan, and antihelminthic drugs?

검증된 단계별 안내

Identify the common challenges faced by antimicrobial drugs targeting viruses, fungi, protozoa, and helminths by considering their biological differences from bacteria and human cells.

Understand that one major problem is selective toxicity, which means the drug must harm the pathogen without damaging the host's cells; this is difficult because these pathogens are eukaryotic (like human cells) or have complex life cycles.

Recognize that drug resistance can develop in these pathogens, similar to bacteria, making treatment less effective over time.

Consider the issue of toxicity and side effects, as drugs targeting eukaryotic pathogens often affect human cells due to similarities, leading to adverse reactions.

Note that the complexity of the pathogens' life cycles and their ability to hide within host cells or tissues can make it difficult for drugs to reach and effectively eliminate them.

비슷한 문제에 대한 검증된 영상 답변:

이 영상 해법은 위 문제에 도움이 된다고 튜터들이 추천한 것입니다.

영상 길이:

주요 개념

질문에 올바르게 답하기 위해 반드시 이해해야 하는 핵심 개념들은 다음과 같습니다.

Selective Toxicity

Selective toxicity refers to the ability of a drug to target pathogens without harming the host. Antiviral, antifungal, antiprotozoan, and antihelminthic drugs often struggle with this because these pathogens share many cellular features with human cells, making it difficult to kill the pathogen without damaging host tissues.

Drug Resistance

Drug resistance occurs when pathogens evolve mechanisms to survive exposure to drugs designed to kill them. This is a common problem across antiviral, antifungal, antiprotozoan, and antihelminthic treatments, leading to reduced drug efficacy and the need for new or combination therapies.

Limited Drug Targets

Many eukaryotic pathogens and viruses have fewer unique biochemical pathways or structures compared to bacteria, limiting the number of effective drug targets. This scarcity complicates the development of drugs that can specifically inhibit these pathogens without affecting human cells.